Consequently, IL-17 was a potential biomarker reflecting the severity of IDD degree, and inhibitors which blocked IL-17 and IL-17RA could be served as an important direction for future clinical drug discovery. Here, IL17A is linked to intervertebral disk degenerative disorder.